Genetically Modified Cells TRIZ Cases

Overexpressing MYC and BMI1 genes in hematopoietic progenitors enables stable myeloid expansion while avoiding cancer risks associated with immortalized lines.

Knocking out LDHA and PDK1 genes reduces lactate accumulation in fed-batch processes, maintaining high viable cell density.

Induced hepatic stem cells replicate human liver metabolic functions using defined gene combinations.

Sox17-expressing reprogrammed endothelial cells overcome instability and immature cell issues to enable durable vascular regeneration.

Bispecific autoantibodies overcome antigen heterogeneity by targeting secreted proteins, recruiting T cells to enhance cytolytic activity.

Defined nucleic acid fragment with recombinase-mediated recombination eliminates random integration screening.

Co-culturing immortalized cells with mesenchymal stem cells produces homogeneous cancer stem cell lines with reduced chromosomal aberrations.

Disrupting host fertility genes eliminates endogenous gamete competition, ensuring reliable donor cell integration into chimeric offspring.

A cell culture medium containing lithium ions, ethanol, and fatty acids increases recombinant polypeptide titers.

Adding cytokines and N-acetylcysteine to culture media expands T cell populations while maintaining genetic alterations.

Optimized human BDCA-2 antibody variable regions bind pDCs to inhibit IFNα production.

Direct transdifferentiation of fibroblasts via Tbet, Tcf7, and Ets1 bypasses pluripotent stem cell complexity for scalable CAR-T production.

Culturing neural stem cells with non-integrating vectors expressing reprogramming factors to generate pluripotent stem cell clones.

Transfecting marrow stromal cells with Notch intracellular domain nucleic acids alters developmental potential.

FoxP3-expressing T regulatory cells inhibit apoptosis and inflammation in ovarian tissues, restoring function despite unclear cellular mechanisms.

Induced pluripotent stem cell cultures enable in vitro gene therapy vector infection and nucleic acid extraction for expression analysis.

Engineered stem cells overexpress KCNN4 genes to hyperpolarize transmembrane potential and enhance cellular reparative functions.

Engineered CAR regulatory T cells recognize transplant antigens to induce localized immune tolerance.

Adding meta-tyrosine to the medium raises specific productivity by 5-25% while avoiding apoptosis from traditional valproic acid shifts.

Eliminating endogenous genes from human chromosomes creates safe vectors for clinical use, avoiding contamination from mouse or chicken cell lines.

A non-integrating vector system delivers reprogramming factors to generate induced pluripotent stem cells without viral integration.

Retroviral vectors deliver Oct3/4, Sox2, Klf4, and c-Myc to reprogram somatic cells into induced pluripotent stem cells without embryos.

A multiplex screening platform identifies transcription factors driving stem cell differentiation into specific target types.

CXCR3 variant-expressing T cells enhance chemotaxis and proliferation to improve treatment outcomes.

Introducing miRNA-responsive mRNA enables selective cardiomyocyte purification through molecular recognition.

Differentiating hiPSCs into perinatal-like mesenchymal stem cells via defined trophoblast stages.

A Sendai viral vector delivers reprogramming genes into monocytes to generate induced pluripotent stem cells.

The GILA assay replaces soft agar with liquid suspension to enable high-throughput screening of cellular transformation.

Muscle-derived progenitor cells augment bone tissue through targeted cell isolation and enrichment processes.

A microfluidic chip delivers viral particles through a hydrogel matrix to encapsulated target cells for precise gene transfer.

Administering CD33-deficient hematopoietic cells protects normal myeloid lineages from on-target off-leukemia depletion, preserving the hematopoietic system.

Demethylase treatment removes H3K27me3 modifications from pluripotent stem cells to accelerate differentiation into specific cell types.

An ALS gene point mutation reduces herbicide sensitivity by 100 times, enabling broad-spectrum weed control without transgenic modification.

Sequential culture media guide induced pluripotent stem cells through mesoderm and haemogenic endothelium stages to produce targeted cell populations.

MSU-TnT4 insect cell line enables high-level production of human membrane proteins using recombinant baculoviruses.

A stem cell stress detection system measures potency factors to identify sub-morbid stress without causing cell death.

Site-directed recombination integrates delivery vectors onto autonomously replicating nucleic acids using a single selectable marker for sequential loading.

Inactivating lineage specifier genes in oligopotent stem cells reduces production costs by eliminating recombinant growth factors.

Replacing Klf4 with GLIS1 or PTX family members improves reprogramming success rates by resolving low efficiency trade-offs in standard four-factor protocols.

Adapting cell lines to serum-free suspension culture reduces domestication time and host cell protein content.

A method to generate immortalized cardiac fibroblasts with an Fhl1 gene knockout using viral induction and CRISPR-Cas editing.

Direct reprogramming of somatic cells into functional osteoblasts bypasses pluripotent stages to reduce tumorigenesis risks and invasive collection procedures.

Exogenous miRNAs induce oligodendrocytic differentiation by downregulating connective tissue growth factor, resolving incomplete maturation.

A chemically defined culture system produces human retinal progenitor cells using a Pax6D reporter construct for automated identification.

Recombinant B lymphocyte cell lines express exogenously incorporated membrane immunoglobulins and secreted cytokines.

Engineered genetic circuits regulate megakaryocyte maturation within a 3D microenvironment, resolving low production capacity limits.

Dynamic WNT and BMP signaling specifies primordial germ cells, resolving heterogeneity in stem cell differentiation.